Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 72.68 USD 0.25%
Market Cap: 16.5B USD
Have any thoughts about
Hologic Inc?
Write Note

Hologic Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hologic Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Hologic Inc
NASDAQ:HOLX
Free Cash Flow
$1.1B
CAGR 3-Years
-19%
CAGR 5-Years
16%
CAGR 10-Years
10%
Becton Dickinson and Co
NYSE:BDX
Free Cash Flow
$3.1B
CAGR 3-Years
-4%
CAGR 5-Years
5%
CAGR 10-Years
11%
Boston Scientific Corp
NYSE:BSX
Free Cash Flow
$2.2B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Free Cash Flow
$3.2B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Free Cash Flow
$6.5B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Free Cash Flow
$586m
CAGR 3-Years
-32%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
No Stocks Found

Hologic Inc
Glance View

Market Cap
16.8B USD
Industry
Health Care
Economic Moat
None

Hologic Inc., headquartered in Marlborough, Massachusetts, crafts a narrative deeply intertwined with the vital mission of women's health. Established in 1985, the company has grown into a prominent player in the medical device and diagnostics realm. Hologic’s success is anchored in its core business sectors: Breast & Skeletal Health, Diagnostic Solutions, GYN Surgical, and Medical Aesthetics. The cornerstone of this expansive operation is innovation, driving the development of advanced technologies like 3D mammography systems that revolutionize breast cancer detection. This strategic focus on high-value diagnostics and medical equipment allows Hologic to capture significant market share, ensuring a steady revenue stream from both capital equipment sales and ongoing service and maintenance contracts. Beyond its robust presence in imaging and diagnostics, Hologic amplifies its influence through a comprehensive array of solutions for early stage disease detection and treatment. Their Diagnostic Solutions arm, particularly strengthened by molecular diagnostic tests, is a response to the increasing global demand for rapid and accurate testing solutions—a need only intensified by recent global health challenges. These products not only provide critical tools for healthcare professionals but also secure recurring income for Hologic through the sale of consumables and tests. By embedding itself in the cycles of medical advancements and enhancing the standard of care, Hologic generates sustainable growth and remains a crucial ally in both public and specialized health sectors. The company’s blend of technology-driven products and strategic agility enables it to navigate dynamic markets while maintaining a resolute focus on improving health outcomes around the world.

HOLX Intrinsic Value
80.57 USD
Undervaluation 10%
Intrinsic Value
Price

See Also

What is Hologic Inc's Free Cash Flow?
Free Cash Flow
1.1B USD

Based on the financial report for Sep 28, 2024, Hologic Inc's Free Cash Flow amounts to 1.1B USD.

What is Hologic Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
10%

Over the last year, the Free Cash Flow growth was 27%. The average annual Free Cash Flow growth rates for Hologic Inc have been -19% over the past three years , 16% over the past five years , and 10% over the past ten years .

Back to Top